No Genetic Overlap between Circulating Iron Levels and Alzheimer's Disease

Michelle K. Lupton, Beben Benyamin, Petroula Proitsi, Dale R. Nyholt, Manuel A. Ferreira, Grant W. Montgomery, Andrew C. Heath, Pamela A. Madden, Sarah E. Medland, Scott D. Gordon, Simon Lovestone, Magda Tsolaki, Iwona Kloszewska, Hilkka Soininen, Patrizia Mecocci, Bruno Vellas, John F. Powell, Ashley I. Bush, Margaret J. Wright, Nicholas G. MartinJohn B. Whitfield

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Iron deposition in the brain is a prominent feature of Alzheimer's disease (AD). Recently, peripheral iron measures have also been shown to be associated with AD status. However, it is not known whether these associations are causal: do elevated or depleted iron levels throughout life have an effect on AD risk? We evaluate the effects of peripheral iron on AD risk using a genetic profile score approach by testing whether variants affecting iron, transferrin, or ferritin levels selected from GWAS meta-analysis of approximately 24,000 individuals are also associated with AD risk in an independent case-control cohort (n∼10,000). Conversely, we test whether AD risk variants from a GWAS meta-analysis of approximately 54,000 account for any variance in iron measures (n∼9,000). We do not identify a genetic relationship, suggesting that peripheral iron is not causal in the initiation of AD pathology.

Original languageEnglish
Pages (from-to)85-99
Number of pages15
JournalJournal of Alzheimer's Disease
Volume59
Issue number1
DOIs
StatePublished - 2017

Keywords

  • Alzheimer's disease
  • apolipoproteins E
  • dementia
  • ferritin
  • genetic profile scores
  • genome-wide association study
  • iron
  • population genetics
  • transferrin

Fingerprint

Dive into the research topics of 'No Genetic Overlap between Circulating Iron Levels and Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this